Clinical Trials Logo

Filter by:
NCT ID: NCT03308630 Completed - Headache Clinical Trials

Immediate Effect of Energy Alignment and Mantra on Stress Related Pain in Adolescents

Start date: June 28, 2017
Phase: N/A
Study type: Interventional

Psychiatrists have expressed concern at the emergence of education as a serious source of stress for school-going children - causing high incidence of deaths by suicide. Many adolescents in India are referred to hospital psychiatric units for school-related distress - exhibiting symptoms of depression, high anxiety, frequent school refusal, phobia, physical complaints, irritability, weeping spells, and decreased interest in school work. Previous studies have found significant anxiety, distress, depression, worn outs and severe impact of psychological factors on the performances of dental, engineering and medical student. But students preparing for competitive exams have not been studied yet. Current study reports the scientific evidence of immediate effect of yoga based techniques combined with music and Vedic chants on adolescents preparing for competitive exams.

NCT ID: NCT03307551 Not yet recruiting - Surgery Clinical Trials

Evaluation of Automated Propofol Delivery in Patients Undergoing Thoracic Surgery

Start date: November 2017
Phase: Phase 4
Study type: Interventional

Automated delivery of propofol using computer-controlled closed loop anaesthesia device delivers propofol based on patient's frontal cortex electrical activity as determined by bi-spectral index (BIS). Evaluation of anaesthesia delivery by these systems has shown that they deliver propofol and maintain depth of anaesthesia with far more precision as compared to manual administration. By automatically controlling anaesthesia depth consistency they provide time to the anaesthesiologist to focus on other aspects of patient care such as managing intra-operative hemodynamics and ventilation perturbations during major surgeries. Closed loop anaesthesia delivery system (CLADS) is an indigenously developed continuous automated intravenous infusion system which delivers propofol based on patients EEG profile (BIS) feedback. Although a few studies have already evaluated these automated systems in patients undergoing thoracic surgery, but suffered from significant limitations (small number of patients, not dedicated to thoracic surgery cohort). Currently, there is no data available regarding CLADS performance vis a vis adequacy of GA and haemodynamic profile in patients undergoing thoracic surgery. We contend that propofol as delivered by CLADS will proffer greater consistency to anaesthesia depth, intra-operative hemodynamic stability, and rapid recovery upon anaesthesia discontinuation than manual means of delivering propofol TIVA. This randomised controlled study aims to compare the efficiency of CLADS-driven propofol TIVA versus manually controlled propofol TIVA in patients undergoing thoracic surgery.

NCT ID: NCT03306095 Recruiting - Clinical trials for Acute Gastroesophageal Variceal Bleeding

Comparison of Early Vs Delayed Feeding on Rebleeding Following Endoscopic Ligation for Acute Esophageal Variceal Bleeding

Start date: May 2, 2017
Phase: N/A
Study type: Observational [Patient Registry]

Following endoscopic therapy of variceal bleeding, the issue of when to refeed these patients has rarely been investigated. This may imply that feeding is generally regarded as a negligible factor in the management of bleeding varices. On the other hand, it is usually believed that systematic fasting is required in case of patients with upper gastrointestinal bleeding. Some researchers in their studies demonstrated that immediate refeeding has similar outcomes to delayed refeeding among patients with low risk of nonvariceal bleeding. The situation of variceal bleeding is quite different from that of peptic ulcer bleeding as demonstrated by studies of other researchers who made a review on feeding of patients with upper gastrointestinal bleeding, and recommended that feeding should be delayed for at least 48 hours after endoscopic therapy because early refeeding may cause a shift in blood flow to the splanchnic circulation, which in turn could lead to an increase in pressure and an increased risk of rebleeding from the varices. The other important reason of delay in feeding may be ascribed to the fear of occurrence of early rebleeding induced by refeeding. In addition, repeated endoscopic examination and therapy may be required in patients with very early rebleeding. The decision to delay feeding is usually based on clinicians 'experience or experts' opinion rather than evidence based. That is why we planned this study.

NCT ID: NCT03304457 Recruiting - Schizophrenia Clinical Trials

Effect of Lurasidone Vs Olanzapine on Neurotrophic Biomarkers in First Episode Untreated Schizophrenia

Start date: August 25, 2017
Phase: Phase 4
Study type: Interventional

Schizophrenia (SCZ) is a chronic, severe and disabling mental disorder with unclear etiology and pathophysiology concerned with neuro-developmental,neurodegenerative abnormalities and cognitive impairmentslinked to behavioural changes.According to neurotrophic hypothesis, the changes result due to the abnormal regulation of neurotrophic factor, especially the decreased serum brain derived neurotrophic factor (BDNF) validated by several meta-analyses. However, the regulation of nerve growth factor (NGF) in SCZ remains unclear because of the inconsistent findings from the previous clinical studies. Lurasidone is a novel antipsychotic drug approved for adult SCZ and for affective symptomatology & cognitive deficits. Principal advantages over some other second-generation antipsychotics are its highly favourable metabolic profile and once daily dosing regimen. Some of the studies indicate that risperidone, olanzapine, clozapine & aripiprazole might not alter BDNF levels, at least within 8 weeks of treatment.While other two studies with olanzapine suggest that BDNF might influence the response to monotherapy in SCZ patients.All these previous studies are non-conclusive & contradictory to each other which draw our attention for doing the research further to reach a conclusive result about the effect of olanzapine and lurasidone on neurotrophic biomarkers in SCZ.

NCT ID: NCT03298451 Not yet recruiting - Clinical trials for Hepatocellular Carcinoma

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma

Start date: October 30, 2017
Phase: Phase 3
Study type: Interventional

This is a randomized, open-label, multi-center, global, Phase III study to assess the efficacy and safety of durvalumab plus tremelimumab combination therapy and durvalumab monotherapy versus sorafenib in the treatment of patients with no prior systemic therapy for unresectable HCC. The patients cannot be eligible for locoregional therapy.

NCT ID: NCT03296644 Active, not recruiting - Clinical trials for Class II Division 1 Malocclusion

Comparison of Treatment Effects of PowerScope and Forsus Using CBCT

Start date: August 16, 2016
Phase: N/A
Study type: Interventional

The main objective of this prospective, controlled clinical study is: 1. To compare the treatment effects of PowerScope and Forsus Fatigue Resistant Device in patients with Class II divison1 malocclusion. 2. To compare the treatment effects of PowerScope and Forsus Fatigue Resistant Device with the control group. The null hypothesis for this study is that Forsus and PowerScope are equally effective in the treatment of ClassII div1 malocclusion.

NCT ID: NCT03296163 Not yet recruiting - Clinical trials for Non-small Cell Lung Cancer

A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Start date: December 2017
Phase: Phase 3
Study type: Interventional

This is a multicenter, multinational, double-blind, 1:1 randomized, parallel-group, equivalence Phase 3 study to compare the efficacy and safety of MB02 plus chemotherapy (carboplatin and paclitaxel) versus Avastin® plus chemotherapy (carboplatin and paclitaxel) in subjects with Stage IIIB/IV non-squamous NSCLC

NCT ID: NCT03295461 Completed - Periodontitis Clinical Trials

Emblica Officinalis Irrigation in Periodontitis

Start date: March 2013
Phase: N/A
Study type: Interventional

E. officinalis fruit possesses both the antimicrobial and anti-inflammatory activities that may prove to be useful against several periodontal diseases with the advantage that it is devoid of side effects associated with synthetic drugs. After the careful search of literature, none of the studies have reported the effect of local drug delivery of E. officinalis preparations on chronic periodontitis.The present study is designed with the aim of assessing the effectiveness of Emblica officinalis extract formulations as a potential adjunctive therapeutic strategy in the management of chronic periodontititis

NCT ID: NCT03295292 Recruiting - Clinical trials for Corneal Haze After Photo Therapeutic/Refractive Keratectomy

Stem Cells for Corneal Haze

Start date: August 1, 2017
Phase: Phase 1
Study type: Interventional

This is a investigator-initiated pilot clinical trial to ascertain the safety and efficacy of application of ex-vivo cultivated limbal stem cells in human eyes for treating Corneal Haze after Photo-Therapeutic/Refractive Keratectomy (PTK/ PRK) and Collagen Cross Linking (CXL). Instead of using adjunctive medical therapy like application of MMC (Mitomycin), a technique of cell delivery with fibrin sealant can be used. These cells are harvested from therapeutically accepted and serologically tested cadaveric corneas. The isolated limbal epithelial and mesenchymal or stromal cell suspension will then be cultured in CGMP laboratories and be tested for sterlity. These cells have also been shown to be effective in treating haze in laser refractive surgery in an animal model. Our initial experience of using these cells in a previous clinical trial showed that they were effective in preventing corneal haze in patients with burns and ulcers.

NCT ID: NCT03293459 Recruiting - Cirrhosis Clinical Trials

Influence of Balloon Occluded Retrograde Transvenous Obliteration on Organ Functions in Hyperammonemic Cirrhotics With Shunt

Start date: July 3, 2017
Phase: N/A
Study type: Interventional

The spontaneous gastrorenal shunt is occluded in the Balloon Occluded Retrograde Transvenous Obliteration (BRTO) procedure resulting in diversion of blood flow toward the portal circulation and in turn the liver. According to this investigator hypothesise that BRTO improves liver volume and function along with beneficial effect on other organ systems by decreasing ammonia and improving hepatopetal flow. All cirrhotics with large shunt(>10mm) and raised ammonia levels and will be randomized to receive standard medical treatment and those with BRTO. Investigator will assess organ functions and liver regenerative potential pre and post(after 3months) procedure.